Antiemetic Drugs – What to Prescribe and When
Vomiting is one of the most common adverse events (AE) in clinical trials. While most AEs are mild and self-resolving, cases of moderate to severe emesis are not infrequent and can impact the safety of participants and the integrity of study data. Using antiemetics is often necessary to manage these AEs and enhance drug absorption. However, the choice of specific medications depends on various factors, such as the intensity of event, underlying causes, study population and study objectives. This infographic provided by BioPharma Services offers a comprehensive overview and concise recommendations concerning therapeutic strategies for managing vomiting events.
To download the PDF document – Click Here.
This infographic is designed for professional use, offering an overview based on literature and in-house experience from clinical trials involving healthy volunteers. It aims to provide guidance on handling vomiting events to ensure subjects’ safety and maintain study data integrity.
Addressing adverse events (AEs) during clinical trials requires careful consideration and a blend of scientific knowledge, medical expertise, and clinical experience from physicians in the selection of appropriate therapeutic options. Collaborating with an experienced clinical trial services company such as BioPharma Services ensures your studies are conducted with quality and led by skilled pharmacokinetic professionals and physicians.
Contact us today to learn more about partnering with us as your next clinical research organization (CRO).
BioPharma Services, Inc., a Think Research Corporation and clinical trial services company, is a full-service Contract Clinical Research Organization (CRO) based in Toronto, Canada, specializing in Phase 1 clinical trials 1/2a and Bioequivalence clinical trials for international pharmaceutical companies worldwide. BioPharma conducts clinical research operations from its Canadian facility, with access to healthy volunteers and special populations.
